AstraZeneca Sues Again Over Breast Cancer Drug Patents
AstraZeneca has hit more generic-drug makers with a patent infringement suit in New Jersey federal court over a generic alternative to Faslodex, its injection-administered drug for battling breast cancer past menopause....To view the full article, register now.
Already a subscriber? Click here to view full article